Clinical features and immunohistochemistry profile of biopsy-proven gastric gastrointestinal stromal tumor (GIST): a description of 5 years case series and literature review of GIST

[1]Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006; 23:70–83.MiettinenMLasotaJGastrointestinal stromal tumors: pathology and prognosis at different sitesSemin Diagn Pathol200623708310.1053/j.semdp.2006.09.001Search in Google Scholar

[2]Ducimetiere F, Lurkin A, Ranchere-Vince D, Decouvelaere AV, Peoc’h M, Istier L, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PloS One. 2011; 6:e20294.DucimetiereFLurkinARanchere-VinceDDecouvelaereAVPeoc’hMIstierLIncidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testingPloS One20116e2029410.1371/journal.pone.0020294Search in Google Scholar

[3]El-Menyar A, Mekkodathil A, Al-Thani H. Diagnosis and management of gastrointestinal stromal tumors: an up-to-date literature review. J Can Res Ther. 2017; 13:889–900.El-MenyarAMekkodathilAAl-ThaniHDiagnosis and management of gastrointestinal stromal tumors: an up-to-date literature reviewJ Can Res Ther201713889900Search in Google Scholar

[4]Bamboat ZM, Dematteo RP. Updates on the management of gastrointestinal stromal tumors. Surg Oncol Clin N Am. 2012; 21:301–16.BamboatZMDematteoRPUpdates on the management of gastrointestinal stromal tumorsSurg Oncol Clin N Am2012213011610.1016/j.soc.2011.12.004Search in Google Scholar

[5]Yan BM, Kaplan GG, Urbanski S, Nash CL, Beck PL. Epidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: a population-based study. Int J Surg Pathol. 2008; 16:241–50.YanBMKaplanGGUrbanskiSNashCLBeckPLEpidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: a population-based studyInt J Surg Pathol2008162415010.1177/1066896907306967Search in Google Scholar

[6]Wang ZH, Liang XB, Wang Y, Ma GL, Qu YQ, Tian XW. [Epidemiology survey of gastrointestinal stromal tumor in Shanxi Province in 2011]. Zhonghua yi xue za zhi. 2013; 93:2541–4.WangZHLiangXBWangYMaGLQuYQTianXW[Epidemiology survey of gastrointestinal stromal tumor in Shanxi Province in 2011]Zhonghua yi xue za zhi20139325414Search in Google Scholar

[7]Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Can. 2002; 38(Suppl 5):S39–51.MiettinenMMajidiMLasotaJPathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a reviewEur J Can200238Suppl 5S395110.1016/S0959-8049(02)80602-5Search in Google Scholar

[8]Kramer K, Knippschild U, Mayer B, Bogelspacher K, Spatz H, Henne-Bruns D, et al. Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST). BMC Cancer. 2015; 15:57.KramerKKnippschildUMayerBBogelspacherKSpatzHHenne-BrunsDImpact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST)BMC Cancer2015155710.1186/s12885-015-1054-y438437925886494Search in Google Scholar

[9]Oppelt PJ, Hirbe AC, Van Tine BA. Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review. J Gastro Oncol. 2017; 8:466.OppeltPJHirbeACVanTine BAGastrointestinal stromal tumors (GISTs): point mutations matter in management, a reviewJ Gastro Oncol2017846610.21037/jgo.2016.09.15550628728736634Search in Google Scholar

[10]Ucar AD, Oymaci E, Carti EB, Yakan S, Vardar E, Erkan N, et al. Characteristics of Emergency Gastrointestinal Stromal Tumor (GIST). Hepatogastroenterology. 2015; 62:635–40.UcarADOymaciECartiEBYakanSVardarEErkanNCharacteristics of Emergency Gastrointestinal Stromal Tumor (GIST)Hepatogastroenterology20156263540Search in Google Scholar

[11]Caterino S, Lorenzon L, Petrucciani N, Iannicelli E, Pilozzi E, Romiti A, et al. Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. World J Surg Oncol. 2011; 9:13.CaterinoSLorenzonLPetruccianiNIannicelliEPilozziERomitiAGastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patientsWorld J Surg Oncol201191310.1186/1477-7819-9-13303961721284869Search in Google Scholar

[12]Sorour MA, Kassem MI, Ghazal Ael H, El-Riwini MT, Abu Nasr A. Gastrointestinal stromal tumors (GIST) related emergencies. Int J Surg. 2014; 12:269–80.SorourMAKassemMIGhazalAel HEl-RiwiniMTAbuNasr AGastrointestinal stromal tumors (GIST) related emergenciesInt J Surg2014122698010.1016/j.ijsu.2014.02.00424530605Search in Google Scholar

[13]Luo J-M, Cao F-L, Meng C, Lin L-J, Ma S-Q, Peng S-H, et al. Clinicopathological and molecular characteristics of synchronous gastric adenocarcinoma and gastrointestinal stromal tumors. Sci Rep. 2017; 7:12890.LuoJ-MCaoF-LMengCLinL-JMaS-QPengS-HClinicopathological and molecular characteristics of synchronous gastric adenocarcinoma and gastrointestinal stromal tumorsSci Rep201771289010.1038/s41598-017-12622-x563510429018259Search in Google Scholar

[14]Raza MA, Shahab AS, Mazzara P. Gastrointestinal stromal tumors: association with Helicobacter pylori gastritis. Am J Clin Pathol. 2012; 138:A351.RazaMAShahabASMazzaraPGastrointestinal stromal tumors: association with Helicobacter pylori gastritisAm J Clin Pathol2012138A35110.1093/ajcp/138.suppl1.327Search in Google Scholar

[15]Gopie P, Mei L, Faber AC, Grossman SR, Smith SC, Boikos SA. Classification of gastrointestinal stromal tumor syndromes. Endocr Relat Cancer. 2018; 25:R49–58.GopiePMeiLFaberACGrossmanSRSmithSCBoikosSAClassification of gastrointestinal stromal tumor syndromesEndocr Relat Cancer201825R495810.1530/ERC-17-0329Search in Google Scholar

[16]Emile JF, Théou N, Tabone S, Cortez A, Terrier P, Chaumette MT, et al. Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors. Clin Gastroenterol Hepatol. 2004; 2:597–605.EmileJFThéouNTaboneSCortezATerrierPChaumetteMTClinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumorsClin Gastroenterol Hepatol2004259760510.1016/S1542-3565(04)00243-5Search in Google Scholar

[17]Miettinen M, Lasota J. Gastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Archiv. 2001; 438:1–12.MiettinenMLasotaJGastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosisVirchows Archiv200143811210.1007/s00428000033811213830Search in Google Scholar

[18]Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003; 299:708–10.HeinrichMCCorlessCLDuensingAMcGreeveyLChenCJJosephNPDGFRA activating mutations in gastrointestinal stromal tumorsScience20032997081010.1126/science.107966612522257Search in Google Scholar

[19]Wang JH, Lasota J, Miettinen M. Succinate dehydrogenase subunit B (SDHB) is expressed in neurofibromatosis 1-associated gastro-intestinal stromal tumors (GISTs): implications for the SDHB expression based classification of GISTs. J Can. 2011; 2:90.WangJHLasotaJMiettinenMSuccinate dehydrogenase subunit B (SDHB) is expressed in neurofibromatosis 1-associated gastro-intestinal stromal tumors (GISTs): implications for the SDHB expression based classification of GISTsJ Can201129010.7150/jca.2.90307261421479127Search in Google Scholar

[20]Bajor J. Gastrointestinal stromal tumours in patients with type 1 neurofibromatosis. Clin Exp Med J. 2009; 3:247–54.BajorJGastrointestinal stromal tumours in patients with type 1 neurofibromatosisClin Exp Med J200932475410.1556/CEMED.3.2009.28478Search in Google Scholar

[21]Novelli M, Rossi S, Rodriguez-Justo M, Taniere P, Seddon B, Toffolatti L, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology. 2010; 57:259–70.NovelliMRossiSRodriguez-JustoMTanierePSeddonBToffolattiLDOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumoursHistopathology2010572597010.1111/j.1365-2559.2010.03624.x20716168Search in Google Scholar

[22]Yang ML, Wang JC, Zou WB, Yao DK. Clinicopathological characteristics and prognostic factors of gastrointestinal stromal tumors in Chinese patients. Oncol Lett. 2018; 16:4905–14.YangMLWangJCZouWBYaoDKClinicopathological characteristics and prognostic factors of gastrointestinal stromal tumors in Chinese patientsOncol Lett20181649051410.3892/ol.2018.9320614473230250556Search in Google Scholar

[23]Lim KT, Tan KY. Current research and treatment for gastrointestinal stromal tumors. World J Gastroenterol. 2017; 23:4856.LimKTTanKYCurrent research and treatment for gastrointestinal stromal tumorsWorld J Gastroenterol201723485610.3748/wjg.v23.i27.4856552675628785140Search in Google Scholar

[24]Maki RG. Gastrointestinal stromal tumors (GIST) and their management. Gastrointest Cancer Res. 2007; 1(4 Suppl 2):S81.MakiRGGastrointestinal stromal tumors (GIST) and their managementGastrointest Cancer Res200714 Suppl 2S81Search in Google Scholar

[25]Lanke G, Lee JH. How best to manage gastrointestinal stromal tumor. World J Clin Oncol. 2017; 8:135.LankeGLeeJHHow best to manage gastrointestinal stromal tumorWorld J Clin Oncol2017813510.5306/wjco.v8.i2.135538543428439494Search in Google Scholar

[26]Akahoshi K, Oya M, Koga T, Shiratsuchi Y. Current clinical management of gastrointestinal stromal tumor. World J Gastroenterol. 2018; 24:2806.AkahoshiKOyaMKogaTShiratsuchiYCurrent clinical management of gastrointestinal stromal tumorWorld J Gastroenterol201824280610.3748/wjg.v24.i26.2806604842330018476Search in Google Scholar

[27]Din OS, Woll PJ. Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate. Ther Clin Risk Manag. 2008; 4:149.DinOSWollPJTreatment of gastrointestinal stromal tumor: focus on imatinib mesylateTher Clin Risk Manag2008414910.2147/TCRM.S1526Search in Google Scholar